ISSUE 21 · MAY 28, 2026 · NWL $3.60
In October 2024, a woman bought a Rubbermaid 13-gallon trash can — the kind that costs serious money because you're paying for the name that used to mean indestructible. The lid broke within a year. She went to Rubbermaid's website to file a warranty claim. Other reviews on the same page described the same lid, on the same model, breaking within months. Rubbermaid has a 2.1-star rating on PissedConsumer.
That same quarter, Newell Brands — Rubbermaid's parent company, and the parent of Yankee Candle, Sharpie, Crock-Pot, FoodSaver, Coleman, Paper Mate, Elmer's, Graco, Mr. Coffee, and roughly seventy other brands that furnish American life — reported gross margin expansion of 70 basis points. Management called it progress. The stock was at $4.90 and falling.
Two numbers. One says the turnaround is working. The other says it's hollowing out the thing it's trying to save.
The trade is built on the gap.
Catalyst Calendar — every dated catalyst across every ticker we cover: calendar.turnaroundradar.com

undefined
How Newell got to $3.60
In 2016, Newell Rubbermaid bought Jarden Corporation for $20 billion. Jarden brought Yankee Candle, Coleman, Crock-Pot, FoodSaver, Mr. Coffee, Oster, Sunbeam, Ball (home canning), and dozens more into the fold. The deal was supposed to create a consumer products powerhouse — a house of brands that could compete with Procter & Gamble on shelf space if not on scale.
It did not work.
By 2018, Newell had written down $9 billion in goodwill — nearly half the purchase price, gone in two years. Revenue, which had briefly touched $14.7 billion in 2017 on the combined entity, began a long decline that has not ended. The company sold off assets (Waddington, Pure Fishing, Jostens, the tools business) and shrunk. Revenue fell to $7.27 billion by 2025, a 50.7% decline from the post-acquisition peak. The stock, which traded above $50 before the deal, has not recovered.
In May 2023, Chris Peterson — the company's CFO and president — was promoted to CEO. Peterson inherited a bloated portfolio, a balance sheet carrying $5.0 billion in debt against a market cap of roughly $1.5 billion, and a collection of brands that consumers were increasingly describing in terms like "not the same" and "quality has really gone downhill."
Peterson's turnaround plan has three pillars: restructure the organization (900 layoffs announced December 2025, 20 Yankee Candle stores closed), invest in the "biggest and most profitable" brands, and cut China sourcing exposure below 10% (achieved). In December 2025, the company launched a "Global Productivity Plan" to save $75-90 million annually.
The 52-week high was $6.64 in July 2025. By April 2026, the stock touched a 52-week low of $3.07. It closed at $3.60 on May 26 — down 45.2% from the high.
On May 1, 2026, Newell reported Q1 2026 results that beat expectations: revenue of $1.55 billion (vs. $1.51B consensus), EPS of -$0.05 (vs. -$0.09 expected), and raised full-year guidance to flat-to-2% net sales growth with normalized EPS of $0.56-$0.60. The stock bounced 17% intraday.
The question is whether the bounce is the start of a recovery or a dead cat in a brand graveyard.

undefined
What the financials show
The P&L is improving. Revenue is not.
Metric | FY2024 | FY2025 | FY2026 Guide | Reality check |
|---|---|---|---|---|
Revenue | $7.59B | $7.27B (-4.2%) | Flat to +2% | 9th year below $10B |
Gross margin | ~32.0% | ~33.0% | Expanding | 70-100bps improvement |
Norm. op. margin | ~4.5% | ~5.0% | 8.6-9.2% | Requires restructuring |
Normalized EPS | $0.29 | $0.31 | $0.56-$0.60 | Near-doubling |
Total debt | $5.2B | $5.0B | Targeting paydown | $1.74B due by 2028 |
Cash | ~$200M | $229M | — | Thin vs debt load |
Debt/EBITDA | ~7.5x | ~7.1x | Target: <6x | Distressed territory |
The story this table tells is "financial engineering in progress." Margins are expanding through cost cuts and restructuring. Revenue is stabilizing. But the leverage ratio — 7.1x debt-to-EBITDA with $1.74 billion maturing by 2028 — means the company has almost no room for error. If revenue declines resume, the refinancing math gets ugly.
Methodology and sample sizes
Newell Brands is a conglomerate with 80+ brands. Consumer-voice data is diffuse — no single "Newell Brands" storefront exists on Trustpilot the way a Lululemon or Peloton does. The research aggregates across the five largest consumer-facing sub-brands, plus the corporate entity, supplemented by employee and financial-disclosure analysis.
Channel | Sample | Window | What it measures |
|---|---|---|---|
Consumer reviews | ~421 | 12-36mo | Brand satisfaction |
Yankee Candle (Sitejabber) | 200 reviews, 1.3/5 | Lifetime | Scent quality, tunneling |
Rubbermaid (PissedConsumer) | 31 reviews, 2.1/5 | Lifetime | Durability, warranty |
Newell Corp (Trustpilot) | ~50 reviews, 1.8/5 | Lifetime | Corporate service |
Crock-Pot (Amazon est.) | ~100 reviews, 2.5/5 | 12 months | Nonstick coating defect |
FoodSaver (BBB + Amazon) | ~40 reviews, 2.3/5 | 12 months | Warranty denial |
BBB complaints | 150+ | 3 years | Warranty, service |
Employee (Glassdoor) | 1,733 reviews, 3.2/5 | 24 months | Morale, CEO approval |
Financial disclosure | SEC filings | FY2024-Q1 2026 | Revenue, margins, debt |
Important caveat on consumer-voice data: Newell's brands are sold primarily through third-party retailers (Walmart, Target, Amazon, Home Depot). The complaint platforms capture warranty and service failures disproportionately. The aggregate (N=421) meets minimum thresholds but the per-brand samples for Rubbermaid (n=31) and FoodSaver (n=40) are below our preferred floor of 100. Statistical tests are run on Yankee Candle (n=200) where the sample is sufficient.
Statistical test: Is Yankee Candle's customer satisfaction significantly below industry baseline?
Yankee Candle is Newell's most visible consumer brand and the one with the deepest review pool. On Sitejabber, it carries a 1.3-out-of-5 rating on 200 reviews. The 1-star share is 75%.
The industry baseline for consumer products brands on Sitejabber and similar complaint-weighted platforms is approximately 15% one-star reviews (median across home and fragrance categories).
Two-proportion Z-test:
Observed 1-star share (Yankee Candle): 75.0% (150 of 200)
Baseline 1-star share (industry): 15.0%
Z = 23.76, p < 0.001
95% confidence interval for excess 1-star share: 54.0 to 66.0 percentage points above baseline
The result is unambiguous. Yankee Candle's review profile is not a borderline case. It is an extreme outlier — five standard deviations above the industry baseline for negative reviews. The recurring complaints — candles that don't throw scent, tunneling despite following instructions, wick burn-down leaving half the wax unmelted — describe a product that has changed, not a customer base that has become harder to please.

undefined
Statistical test: Revenue trajectory and the Jarden hangover
Revenue has declined from $14.74B (2017, post-Jarden) to $7.27B (2025). Is this a statistically significant trend, or does the 2021 COVID-era rebound ($10.59B) break the pattern?
Mann-Kendall trend test (2017-2025 annual revenue):
Kendall's tau = -0.611
p = 0.025
Interpretation: Statistically significant downward trend at the 5% level
Even including the 2021 rebound, the overall trajectory is declining at a rate of approximately $480 million per year (post-2018 linear trend). The Jarden acquisition has been a value destroyer for nine consecutive years.
The counterargument: Peterson's turnaround is designed to stop this decline. Q1 2026 showed revenue declining only 1.1% (vs. -4.2% in FY2025). If Q2 2026 shows flat or positive growth, the trend may be breaking. That's why July 31 matters.
What the financials do not show
The financials show margin expansion. What they do not show is where the margin is coming from.
There are two ways to expand gross margin. One is to sell better products at higher prices. The other is to make cheaper products and cut costs. The P&L looks the same either way — for a while.
Newell's margin expansion is coming from the second path. The productivity plan is cutting headcount, closing stores, reducing SKUs, and squeezing procurement. These are legitimate turnaround levers. But when the customer-facing evidence — a Crock-Pot class action over coating that peels, Rubbermaid lids that break within a year, Yankee Candle scent complaints at scale — tells a story of product quality declining simultaneously with margin improving, the financial narrative and the product narrative are moving in opposite directions.
This is the gap. The P&L says recovery. The product says decay. Both are true right now. The question is which one eventually dominates.
Peterson knows this. On the Q1 2026 call, management highlighted "25 Tier 1 and Tier 2 innovations launching in 2026, up from 18 last year" and emphasized the decision to "disproportionately invest in the largest and most profitable brands." The turnaround thesis depends on the innovation pipeline replacing the quality that cost-cutting removed. It has not happened yet — but the next two quarters are the test.

undefined
What is actually happening, and what is not
Recovering:
Gross margin (expanding 70-100bps per year through productivity and tariff mitigation)
China sourcing dependency (below 10%, down from ~30%+, a structural advantage)
Revenue deceleration (from -7.3% to -1.1%, approaching flat)
Management focus (Peterson is cutting the portfolio to concentrate on winners)
Tariff positioning ($2B invested in US/Mexico manufacturing gives tariff-advantaged share wins)
NOT recovering:
Consumer brand health (1.80/5 weighted average across portfolio, every brand below industry benchmark)
Employee morale (Glassdoor flat at 3.2/5 for two years, constant restructuring fatigue)
Revenue growth (still negative, nine years of decline from Jarden peak)
Debt load ($5.0B on a $1.5B market cap, 7.1x leverage, $1.74B maturing by 2028)
Unknown:
Whether the 25 innovation launches in 2026 actually move the needle on brand perception
Whether the $0.56-$0.60 EPS guide is achievable if tariffs escalate beyond current assumptions
Whether the 2027-2028 debt maturities can be refinanced at tolerable rates given the leverage ratio
Whether Yankee Candle's quality decline is reversible or structural (formula changed post-Jarden)
Important caveats
1. Consumer-voice sample sizes are thin for a conglomerate. Newell's brands are sold through Walmart, Target, Amazon, and Home Depot. The complaint platforms capture warranty/service failures, not the full customer experience. The 421-review aggregate is sufficient for directional findings but below TR's preferred depth for single-brand analyses.
2. The Yankee Candle Z-test (Z=23.76) is powered but platform-specific. Sitejabber skews toward dissatisfied customers. The 75% 1-star share reflects the platform's selection bias. The finding is that Yankee Candle's complaint intensity is extreme even by complaint-platform standards — but it should not be interpreted as "75% of all Yankee Candle customers are dissatisfied."
3. Glassdoor ratings (3.2/5) are not declining — they are flat. The Mann-Kendall test on quarterly Glassdoor ratings shows tau = -0.300, p = 0.297 — no statistically significant trend. Employee morale is not collapsing; it is stagnant. This is better than it looks for a company mid-restructuring.
4. The debt maturity wall is real but manageable if margins continue expanding. At the current trajectory, Newell could generate $400-500M in operating cash flow by 2027 — enough to address the $495M 2027 maturity. The $1.24B 2028 8.5% notes are the harder refinancing challenge.
5. Revenue data from 2017 includes Jarden at full consolidation. The $14.74B peak is not an organic number — it reflects the post-acquisition combined entity. Organic Newell (pre-Jarden) was a ~$5.7B company.

undefined
The setup
The thesis is binary at this price. Either Peterson's turnaround stabilizes revenue and the leverage ratio compresses to refinanceable levels — or it doesn't, and the debt wall becomes a restructuring event.
Scenario | Probability | 12-Mo Target | Thesis |
|---|---|---|---|
Bull: Turnaround accelerates | 25% | $6.00-$7.00 | Q2 positive core sales, EPS $0.60, 2027 refi at <7% |
Base: Grinding recovery | 40% | $4.00-$5.00 | Revenue flat, EPS $0.50-$0.55, slow deleveraging |
Bear: Turnaround stalls | 25% | $2.00-$3.00 | Revenue resumes decline, punitive refi, dilution |
Tail: Restructuring | 10% | $0.50-$1.50 | 2028 maturity unrefinanceable, Chapter 11 risk |
Expected value at current price ($3.60): Weighted 12-month midpoint = $4.35, ~21% upside. But the distribution is wide — the bull case is a near-double, the tail case is a 70-85% wipeout. This is a leverage trade, not a quality trade.
The trade
Now ($3.60): The stock is priced for the bear case. The market is betting the turnaround fails. If you believe Peterson's team can stabilize revenue and manage the debt maturities, the risk/reward is asymmetric — you're buying $7.3B in iconic brand revenue for $1.5B enterprise value (adding back net debt). The Q1 beat and raised guidance support the base case. But the brands are deteriorating at the ground level, and the debt load means one bad quarter can cascade.
Next catalyst (July 31, 2026 — Q2 earnings): This is the decider quarter. Q2 is seasonally strong (outdoor, back-to-school). If core sales turn positive for the first time in two years, the stock re-rates toward $5. If core sales remain negative despite the raised guidance, the market will question whether the turnaround is real or just financial engineering.
Decider date (October 2026 — Q3 + 2027 refinancing clarity): By Q3, the company will need to show consistent sequential improvement AND signal its plan for the $495M 2027 notes. The refinancing terms will reveal what the credit market thinks of the turnaround — and the credit market is usually right about leverage stories before the equity market is.
The July 31 read
When Newell reports Q2 2026 on or around July 31, subscribers will get the follow-up with:
Whether core sales turned positive (the single most important metric)
Updated gross margin trajectory and whether the 8.6-9.2% operating margin guide is tracking
Management commentary on 2027 refinancing plans
Whether the 25 innovation launches are showing up in scanner data or retailer shelf resets
Updated brand health metrics from the review platforms (6-month re-survey)
This is a leverage trade with a named catalyst and a binary outcome. The P&L says recovery. The product says decay. July 31 tells us which one is winning.
Catalyst Calendar — every dated catalyst across every ticker we cover: calendar.turnaroundradar.com
Turnaround Radar covers consumer-facing companies trading 30%+ below their 52-week highs. Every report sources customer reviews, employee data, financial filings, and statistical tests to answer one question: is the turnaround real, or is the stock just cheap? Subscribe to get the follow-up when each catalyst lands.